Related Experiment Video
Updated: Jun 17, 2026

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots
Published on: July 21, 2023
[Marburg I polymorphism of Factor VII-activating protease and cerebral infarction]
Qian Tan1, Huarong Tang, Rongrong Liu
1Department of Hematology, Xiangya Hospital, Central South University, Changsha 410008, China.
Objective:
To determine the relation between Marburg I polymorphism of Factor VII-activating protease (FSAP) and cerebral infarction,and to analyze whether it is one of the risk factors of cerebral infarction.
Methods:
Single strand conformation polymorphism-polymerase chain reaction (SSCP-PCR) was applied for the polymorphism analysis of FSAP in 159 patients with cerebral infarction and 179 non-cerebral infarction subjects.
Results:
The phenotypes of FSAP in both the patients and the control subjects were wild type GG; no mutant of Marburg I was found. But a new gene mutation was tested, which had not been reported, requiring further investigation.
Conclusion:
Marburg I polymorphism of FSAP may not be associated with cerebral infarction.
Insights
The Marburg I polymorphism of Factor VII-activating protease (FSAP) was not found to be associated with cerebral infarction in this study. Further investigation is needed for a newly identified gene mutation.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Context:
- Cerebral infarction is a leading cause of disability and mortality worldwide.
- Genetic factors are increasingly recognized as contributing to the risk of cerebral infarction.
- Factor VII-activating protease (FSAP) is involved in coagulation and inflammation, pathways relevant to thrombotic events like cerebral infarction.
Purpose:
- To investigate the association between the Marburg I polymorphism of FSAP and the risk of cerebral infarction.
- To determine if FSAP Marburg I polymorphism serves as a risk factor for cerebral infarction.
Summary:
- A case-control study was conducted using single strand conformation polymorphism-polymerase chain reaction (SSCP-PCR) to analyze FSAP Marburg I polymorphism in 159 cerebral infarction patients and 179 controls.
- No Marburg I polymorphism (wild type GG) was detected in either the patient or control groups.
- A novel, unreported gene mutation in FSAP was identified, warranting further research.
Impact:
- This study suggests that the FSAP Marburg I polymorphism is unlikely to be a significant risk factor for cerebral infarction.
- The identification of a new FSAP gene mutation opens avenues for future research into its potential role in neurological disorders.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

